Clinical Research Physician – Incretins

Role Summary

Clinical Research Physician – Incretins. The Senior/Executive Director in Diabetes and Obesity Medical Affairs provides expert medical support across local/global business activities, including launch and commercialization planning, regulatory and PRA support, data dissemination, and external scientific engagement. Responsible for leading phase 3b/4 studies, real-world evidence expansion, and cross-functional collaboration to support incretin therapies within obesity and diabetes care.

Responsibilities

• Provide expert medical support for marketed products and strategic planning of the patient journey for the compound.
• Support regulatory affairs and interactions with government agencies for new and supplemental submissions; participate in meetings with regulatory agencies.
• Provide medical support for pricing, reimbursement, and access (PRA) and interact with PRA agencies as needed.
• Lead scientific data dissemination, including conferences, advisory boards, and development of educational program content.
• Plan, start up, and conduct phase 3b/4 studies and related non-clinical activities globally and in affiliates/countries.
• Provide scientific support for incretins within the portfolio; design and execute phase 3b/4 studies and expand real-world evidence and patient-reported outcomes.
• Pre- and post-launch business support, including planning symposia, advisory boards, medical information materials, and training medical personnel.
• Prepare or review scientific information in response to questions from customers or media; follow global SOPs for information requests.
• Develop and maintain collaborations with external scientists and professional societies; provide congress support and participate in data analyses and publications.
• Monitor patient safety during studies and ensure adverse events are tracked per safety policies.

Qualifications

• Medical Doctor; board eligible or certified in Endocrinology or Diabetology, or equivalent training for the country of hire. U.S.-trained physicians must be board eligible/certified.
• Non-U.S. trained physicians must have LCME-compliant education/training.
• Preferred: previous pharmaceutical medical affairs and/or development experience; experience in obesity and/or diabetes; knowledge of the drug development process; ability to balance scientific and business priorities; strong leadership and communication skills; ability to travel domestically and internationally.
• Fluent in English, both written and verbal.

Skills

• Deep understanding of diabetes pathophysiology and clinical management.
• Medical affairs planning for launch; data dissemination and communication across phases and real-world evidence.
• Scientific training of clinical study teams; ability to act as scientific consultant and protocol expert.
• Stakeholder engagement with thought leaders, societies, and regulatory bodies.
• Strong collaboration, negotiation, and organizational skills.

Education

• Medical Doctor degree; board certification/eligibility in endocrinology/diabetology or equivalent clinical training per country.

Additional Requirements

• Domestic and international travel as required to support business needs.